Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland

D J Kilmartin, A D Dick, J V Forrester

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Aims-To establish current epidemiological data, risks, and interventional outcomes of newly diagnosed sympathetic ophthalmia (SO).

Methods-Prospective surveillance took place of all permanently employed ophthalmologists in the UK and Republic of Ireland by a monthly reporting card through the British Ophthalmological Surveillance Unit. Case ascertainment was made of newly diagnosed SO from July 1997 and questionnaire data were returned at baseline, 6 months, and 1 year after diagnosis.

Results-23 patients with newly diagnosed SO were recruited over 15 months, corresponding to a minimum estimated incidence of 0.03/100 000. Baseline data were available on 18 patients, in whom SO occurred after surgery in 11 patients, after retinal surgery alone in six patients, and after accidental trauma in seven patients. 12 of the 16 patients with 1 year follow up had a visual acuity of 6/12 or better. Good visual outcome was related to prompt and adequate systemic immunosuppressive therapy.

Conclusions-The incidence of sympathetic ophthalmia is very low The main current risk is surgery, particularly retinal surgery, but visual prognosis is good if early diagnosis is made and rapid, adequate immunotherapy is commenced.

Original languageEnglish
Pages (from-to)259-263
Number of pages5
JournalBritish Journal of Ophthalmology
Volume84
Publication statusPublished - 2000

Cite this

Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. / Kilmartin, D J ; Dick, A D ; Forrester, J V .

In: British Journal of Ophthalmology, Vol. 84, 2000, p. 259-263.

Research output: Contribution to journalArticle

Kilmartin, D J ; Dick, A D ; Forrester, J V . / Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. In: British Journal of Ophthalmology. 2000 ; Vol. 84. pp. 259-263.
@article{b7355f29019245b39fbd76d268b0cdd0,
title = "Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland",
abstract = "Aims-To establish current epidemiological data, risks, and interventional outcomes of newly diagnosed sympathetic ophthalmia (SO).Methods-Prospective surveillance took place of all permanently employed ophthalmologists in the UK and Republic of Ireland by a monthly reporting card through the British Ophthalmological Surveillance Unit. Case ascertainment was made of newly diagnosed SO from July 1997 and questionnaire data were returned at baseline, 6 months, and 1 year after diagnosis.Results-23 patients with newly diagnosed SO were recruited over 15 months, corresponding to a minimum estimated incidence of 0.03/100 000. Baseline data were available on 18 patients, in whom SO occurred after surgery in 11 patients, after retinal surgery alone in six patients, and after accidental trauma in seven patients. 12 of the 16 patients with 1 year follow up had a visual acuity of 6/12 or better. Good visual outcome was related to prompt and adequate systemic immunosuppressive therapy.Conclusions-The incidence of sympathetic ophthalmia is very low The main current risk is surgery, particularly retinal surgery, but visual prognosis is good if early diagnosis is made and rapid, adequate immunotherapy is commenced.",
author = "Kilmartin, {D J} and Dick, {A D} and Forrester, {J V}",
year = "2000",
language = "English",
volume = "84",
pages = "259--263",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland

AU - Kilmartin, D J

AU - Dick, A D

AU - Forrester, J V

PY - 2000

Y1 - 2000

N2 - Aims-To establish current epidemiological data, risks, and interventional outcomes of newly diagnosed sympathetic ophthalmia (SO).Methods-Prospective surveillance took place of all permanently employed ophthalmologists in the UK and Republic of Ireland by a monthly reporting card through the British Ophthalmological Surveillance Unit. Case ascertainment was made of newly diagnosed SO from July 1997 and questionnaire data were returned at baseline, 6 months, and 1 year after diagnosis.Results-23 patients with newly diagnosed SO were recruited over 15 months, corresponding to a minimum estimated incidence of 0.03/100 000. Baseline data were available on 18 patients, in whom SO occurred after surgery in 11 patients, after retinal surgery alone in six patients, and after accidental trauma in seven patients. 12 of the 16 patients with 1 year follow up had a visual acuity of 6/12 or better. Good visual outcome was related to prompt and adequate systemic immunosuppressive therapy.Conclusions-The incidence of sympathetic ophthalmia is very low The main current risk is surgery, particularly retinal surgery, but visual prognosis is good if early diagnosis is made and rapid, adequate immunotherapy is commenced.

AB - Aims-To establish current epidemiological data, risks, and interventional outcomes of newly diagnosed sympathetic ophthalmia (SO).Methods-Prospective surveillance took place of all permanently employed ophthalmologists in the UK and Republic of Ireland by a monthly reporting card through the British Ophthalmological Surveillance Unit. Case ascertainment was made of newly diagnosed SO from July 1997 and questionnaire data were returned at baseline, 6 months, and 1 year after diagnosis.Results-23 patients with newly diagnosed SO were recruited over 15 months, corresponding to a minimum estimated incidence of 0.03/100 000. Baseline data were available on 18 patients, in whom SO occurred after surgery in 11 patients, after retinal surgery alone in six patients, and after accidental trauma in seven patients. 12 of the 16 patients with 1 year follow up had a visual acuity of 6/12 or better. Good visual outcome was related to prompt and adequate systemic immunosuppressive therapy.Conclusions-The incidence of sympathetic ophthalmia is very low The main current risk is surgery, particularly retinal surgery, but visual prognosis is good if early diagnosis is made and rapid, adequate immunotherapy is commenced.

M3 - Article

VL - 84

SP - 259

EP - 263

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

ER -